The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
one of the things that is associated with an increased risk of breast cancer is if there are prior changes in the breast that suggest abnormal amounts of proliferation or atypical appearing cells which are sort of the pre precancerous stages
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
ADH atypical ductal hyperplasia or alh atypical lobular hyperplasia are lesions that put a woman at slightly greater risk for developing breast cancer in the decades to follow the numeric risk is still pretty small probably only about um uh a half to 1% per year risk of developing breast cancer
so um lcis along with those things we alluded to earlier like atypical ductal hyperplasia atypical lobal hyperplasia sort of a prean a pre precancerous lesion and it does increase the risk of eventually developing breast cancer
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.